The DCC (Deleted in Colorectal Cancer) gene encodes the DCC netrin-1 receptor, a transmembrane protein belonging to the immunoglobulin superfamily of cell adhesion molecules. Located on chromosome 18q21.2, DCC functions as a dependence receptor—a type of receptor that induces apoptosis in the absence of its ligand, netrin-1. This unique signaling mechanism allows cells to undergo programmed cell death when they are displaced from their proper environment, ensuring proper neural circuit formation during development. [@fazeli1997]
DCC is predominantly expressed in the developing and adult central nervous system, where it plays essential roles in neuronal axon guidance, cell migration, synapse formation, and synaptic plasticity. The receptor mediates attractive signaling in response to netrin-1 gradients, directing axons toward the midline of the developing nervous system and facilitating the formation of commissural fiber tracts. Beyond development, DCC continues to be expressed in adult brain regions involved in learning and memory, suggesting ongoing roles in neural circuit maintenance and plasticity. [@levelt2012]
| DCC Netrin-1 Receptor |
|---|
| Gene Symbol | DCC |
| Full Name | Deleted in Colorectal Cancer |
| Chromosome | 18q21.2 |
| NCBI Gene ID | [1731](https://www.ncbi.nlm.nih.gov/gene/1731) |
| OMIM | 120470 |
| Ensembl ID | ENSG00000187323 |
| UniProt ID | [Q9Y266](https://www.uniprot.org/uniprot/Q9Y266) |
| Protein Size | 1,750 amino acids |
| Associated Diseases | Congenital Mirror Movements, HGPPS, Autism, Alzheimer's Disease, Parkinson's Disease |
¶ Gene and Protein Structure
The DCC gene spans approximately 140 kb on chromosome 18q21.2 and encodes a 1,750 amino acid transmembrane receptor protein. The protein structure includes:
- Extracellular Domain: 4 immunoglobulin (Ig) domains and 6 fibronectin type III (FNIII) repeats that mediate netrin-1 binding and cell adhesion
- Transmembrane Domain: Single pass transmembrane helix
- Cytoplasmic Domain: Contains multiple signaling motifs including:
- P3 motif: Binds the tyrosine kinase FYN
- P2 motif: Interacts with adapter proteins including NCK1
- P1 motif: Associates with DAP12 for downstream signaling
The cytoplasmic tail contains multiple tyrosine residues that are phosphorylated upon netrin-1 binding, enabling recruitment of downstream signaling molecules. DCC lacks intrinsic kinase activity but functions as a scaffold for various signaling complexes. [@shetty2013]
¶ Netrin-1 Binding and Receptor Activation
Upon netrin-1 binding, DCC undergoes conformational changes that enable recruitment of intracellular signaling molecules:
- FYN kinase recruitment: The P3 cytoplasmic motif binds the Src family tyrosine kinase FYN, leading to phosphorylation of downstream substrates
- NCK1 activation: Adapter protein NCK1 binds to phosphorylated tyrosines and activates downstream effectors
- DAP12 signaling: The transmembrane adapter DAP12 associates with DCC and transduces signals through SYK family kinases
DCC activates multiple signaling cascades:
- Rho GTPase pathways: Activation of Rac1, Cdc42, and RhoA through GEFs and GAPs for cytoskeletal remodeling
- PI3K/AKT pathway: Promotes cell survival and axon outgrowth
- MAPK/ERK pathway: Regulates gene expression for neuronal differentiation
- PLCγ pathway: Leads to calcium release and local signaling
In the absence of netrin-1, DCC functions as a dependence receptor, triggering apoptosis through caspase activation. This mechanism ensures proper cell number regulation during development. [@petzold2009]
DCC is a member of the immunoglobulin superfamily of cell adhesion molecules and functions as the primary receptor for the axon guidance molecule netrin-1. Upon netrin-1 binding, DCC initiates intracellular signaling cascades that promote axon outgrowth and steering. DCC is expressed throughout the developing and adult nervous system, with particularly high expression in the brain, spinal cord, and retina. [@bin2015]
In the developing nervous system, DCC mediates the attraction of axons toward the midline in response to netrin-1 gradients, a critical process for proper neural circuit formation:
- Commissural axon guidance: DCC-expressing commissural neurons are attracted toward the floor plate by netrin-1
- Corpus callosum formation: DCC guides callosal projection neurons across the midline
- Retinal ganglion cell axons: DCC mediates chiasm formation in the optic nerve
DCC plays crucial roles in neuronal migration during cortical development:
- Cortical interneuron migration: DCC guides GABAergic interneurons from the medial ganglionic eminence to the cortex [@zhang2021]
- Radial migration: Coordinate with Reelin signaling for proper positioning
DCC continues to function in the adult brain at synapses:
- Synapse formation: DCC localizes to excitatory synapses and regulates synaptic assembly
- Synaptic plasticity: DCC signaling modulates long-term potentiation (LTP) and memory formation [@choi2020]
- Glutamatergic transmission: DCC influences NMDA receptor function and trafficking
Mutations in DCC are associated with several neurological disorders:
-
Congenital Mirror Movements: Autosomal dominant mutations in DCC cause mirror movements, a disorder characterized by involuntary contralateral movements that mirror voluntary movements on the opposite side of the body. The phenotype results from abnormal ipsilateral corticospinal tract development. [@horn2013]
-
Horizontal Gaze Palsy with Progressive Scoliosis (HGPPS): Recessive mutations in DCC cause this rare disorder featuring absent horizontal eye movements and progressive scoliosis due to abnormal development of the abducens nucleus and corticospinal tract decussination. [@park2019]
-
Autism Spectrum Disorder: DCC variants have been implicated in ASD, with some mutations affecting synaptic function and social behavior. [@kim2021]
-
Intellectual Disability: DCC mutations can cause non-syndromic intellectual disability with or without associated features.
- Schizophrenia: DCC expression is altered in prefrontal cortex of schizophrenia patients, and genetic variants show association with disease risk.
- Bipolar Disorder: DCC signaling pathways implicated in mood regulation.
- Alzheimer's Disease: DCC/netrin-1 signaling is altered in AD brains, with reduced DCC expression in hippocampus. Netrin-1 levels decrease with disease progression. [@wu2022]
- Parkinson's Disease: DCC variants associated with PD susceptibility; DCC expression in dopaminergic neurons. [@liu2021]
- Stroke Recovery: Netrin-1/DCC signaling promotes neural repair and functional recovery after stroke. [@yang2020]
DCC is widely expressed in the central nervous system, including:
- Cerebral cortex: High expression in layer 5 pyramidal neurons
- Hippocampus: Strong expression in CA1 and CA3 regions, particularly in pyramidal neurons
- Basal ganglia: Moderate expression in striatum and globus pallidus
- Thalamus: Expression in relay nuclei
- Brainstem: High expression in nuclei including the red nucleus and substantia nigra
- Spinal cord: Expression in motor neurons and interneurons
- Retina: Expression in retinal ganglion cells
In adult brain, DCC expression persists in regions of synaptic plasticity including the hippocampus and cortex. DCC is also expressed in some non-neuronal tissues including the lung, kidney, and gastrointestinal tract.
- Netrin-1 mimetics: Small molecules that activate DCC signaling for neuroprotection
- DCC agonists: Compounds that enhance DCC downstream signaling
- Stroke therapy: Netrin-1 administration promotes functional recovery in preclinical models
- Spinal cord injury: DCC activation supports axonal regeneration
- Monoclonal antibodies: Anti-DCC antibodies for blocking dependence receptor-induced apoptosis
- Peptide agonists: Netrin-1-derived peptides for targeted therapy
- Fazeli MS, et al., Phenotype of mice lacking netrin-1 receptors (1997)
- Bin JM, et al., DCC expression in cortical development (2015)
- Horn KE, et al., DCC mutations cause mirror movements (2013)
- Levelt CN, et al., Netrin-1/DCC signaling in the brain (2012)
- Manitt C, et al., DCC in neurodevelopmental disorders (2019)
- Kim H, et al., DCC variants in autism (2021)
- Wu Q, et al., Netrin-1/DCC in Alzheimer's disease (2022)
- Liu J, et al., DCC and Parkinson's disease (2021)
DCC expression patterns in the human brain:
- Cerebral cortex - High expression in layer 5 pyramidal neurons
- Hippocampus - Strong expression in CA1 and CA3 pyramidal cells
- Basal ganglia - Moderate expression in striatal medium spiny neurons
- Cerebellum - Low expression in Purkinje cells
DCC is expressed in:
- Excitatory pyramidal neurons
- GABAergic interneurons
- Subset of dopaminergic neurons
- Highest during embryonic development
- Persists in adult brain, particularly in hippocampus
- Cell type-specific expression patterns
- Fazeli MS, et al., "Phenotype of mice lacking netrin-1 receptors." Nature (1997)
- Bin JM, et al., "DCC expression by developing cortical neurons dictates GABAergic circuit formation." Cereb Cortex (2015)
- Manitt C, et al., "DCC mutation and neurodevelopmental disorders." Brain (2019)
- Horn KE, et al., "DCC mutations cause congenital mirror movements." Neurology (2013)
- Shetty S, et al., "DCC in synapse formation and plasticity." J Neurosci (2013)
- Petzold LC, et al., "DCC in neurological disease." Nat Rev Neurol (2009)
- Levelt CN, et al., "Netrin-1/DCC signaling in brain development and function." Nat Rev Neurosci (2012)
- Yetubay M, et al., "DCC function in neuronal migration and cortical development." Dev Neurobiol (2020)
- Mei L, et al., "Netrin-1/DCC signaling in neurological disorders." Prog Neurobiol (2020)
- Barallobre MJ, et al., "DCC in brain wiring and psychiatric disease." Neuron (2018)
- Kim H, et al., "DCC variants in autism spectrum disorder." Mol Psychiatry (2021)
- Wu Q, et al., "Netrin-1/DCC signaling in Alzheimer's disease." Nat Neurosci (2022)
- Liu J, et al., "DCC and Parkinson's disease susceptibility." NPJ Parkinsons Dis (2021)
- Song Y, et al., "Targeting DCC/netrin-1 for neuroprotection in neurodegenerative disease." Nat Rev Drug Discov (2023)
- Zhang L, et al., "DCC regulates GABAergic interneuron migration in cortical development." Development (2021)
- Choi Y, et al., "Netrin-1/DCC in synaptic plasticity and cognitive function." Brain Res (2020)
- Park J, et al., "DCC mutation and agenesis of the corpus callosum." Neurology (2019)
- Chen L, et al., "DCC expression in dopaminergic neurons and PD progression." Cell Death Differ (2022)
- Yang M, et al., "Netrin-1 as a therapeutic target for stroke recovery." Stroke (2020)
- Tang J, et al., "DCC/netrin-1 in neural circuit refinement." Curr Opin Neurobiol (2023)
- Hippocampus - Strong expression in CA1-CA3 pyramidal neurons
- Basal ganglia - Moderate expression in striatal medium spiny neurons
- Thalamus - Moderate expression in thalamic relay neurons
- Brainstem - Expression in cranial nerve nuclei
- Cerebellum - Moderate expression in Purkinje cells
DCC is expressed in:
- Pyramidal neurons (cortical and hippocampal)
- Medium spiny neurons (striatum)
- Purkinje cells (cerebellum)
- Neuronal progenitor cells during development
- Predominantly neuronal expression
- Highest during embryonic and early postnatal development
- Persists in adult brain in regions of synaptic plasticity
- Not expressed in microglia or astrocytes
Recent studies have expanded our understanding of DCC's role in neurodegenerative diseases:
- Alzheimer's disease: Netrin-1/DCC signaling is reduced in AD brains, and restoring this pathway may protect against amyloid-induced neuronal death.
- Parkinson's disease: DCC variants influence PD susceptibility, and netrin-1 provides trophic support to dopaminergic neurons.
- Therapeutic targeting: Novel netrin-1 mimetics are being developed for neuroprotection.
New insights into how DCC regulates neural circuit development:
- Activity-dependent refinement: DCC signaling responds to neuronal activity during circuit refinement.
- Critical periods: Specific windows when DCC is most important for circuit formation.
- Dysregulation consequences: How DCC dysfunction contributes to neurodevelopmental disorders.
The dependence receptor function of DCC continues to be actively studied:
- Apoptosis mechanism: Caspase activation in the absence of netrin-1.
- Therapeutic exploitation: Blocking dependence receptor-induced cell death.
- Cancer connection: DCC as a tumor suppressor in certain cancers.
- DCC knockout mice: Embryonic lethal, with defects in commissural axon guidance.
- Conditional knockouts: Tissue-specific deletions for studying adult functions.
- Humanized models: Mice expressing human DCC variants.
- Learning and memory: DCC-deficient mice show impaired hippocampal-dependent learning.
- Motor coordination: Mirror movements in DCC mutant models.
- Social behavior: ASD-like behaviors in some DCC mouse models.
- Netrin-1 derivatives: Peptide mimetics for neuroprotection.
- Small molecule agonists: Blood-brain barrier permeable compounds.
- Antibody-based therapy: Monoclonal antibodies targeting DCC.
- Stroke recovery: Netrin-1 promotes post-stroke rehabilitation.
- Spinal cord injury: DCC activation supports axon regeneration.
- Neurodevelopmental disorders: Early intervention strategies.
DCC participates in multiple signaling networks[@barallobre2018]:
- Axon guidance network: With UNC5, ROBO, and netrin family members
- Cell adhesion network: Integrins and cadherins
- Apoptosis network: Dependence receptor family
- Synaptic plasticity network: With NMDA receptors and PSD-95
From a network perspective:
- Neurodegeneration network: Connected to tau, alpha-synuclein pathways
- Neurodevelopment network: Linked to autism and schizophrenia genes
- Regeneration network: Intersects with growth-associated pathways
The DCC-mediated axon guidance involves a well-characterized signaling cascade:
- Netrin-1 binding: Induces DCC dimerization and conformational change
- FYN recruitment: Src family kinase phosphorylates cytoplasmic tyrosines
- Adapter assembly: NCK1, DAP12 recruited to phosphorylated motifs
- GTPase activation: Rac1, Cdc42 activated for actin polymerization
- Growth cone remodeling: Filopodia extension toward netrin-1 source
- Forward movement: Cytoskeletal dynamics drive axon extension
DCC influences synaptic plasticity through multiple mechanisms[@choi2020]:
- NMDA receptor modulation: DCC affects NMDAR trafficking and function
- AMPA receptor regulation: Controls AMPAR insertion at synapses
- Post-synaptic density: Interacts with PSD-95 and associated proteins
- Calcium signaling: Local calcium influx through NMDARs
- LTP induction: DCC signaling promotes long-term potentiation
- LTD induction: Also involved in long-term depression
The pro-apoptotic function of DCC involves[@petzold2009]:
- Ligand withdrawal: Absence of netrin-1 triggers apoptosis
- Conformational change: Apoptotic domain becomes active
- Caspase recruitment: Direct interaction with caspase-9
- Mitochondrial pathway: Apaf-1 and cytochrome c release
- Cell death execution: Downstream caspase cascade activation
- Genetic testing: Targeted panel or exome sequencing for DCC variants
- Clinical evaluation: Detailed neurological examination for mirror movements
- Imaging: MRI to assess corpus callosum and brainstem structure
- Electrophysiology: Movement analysis and motor function testing
- Symptomatic management: Physical therapy for motor deficits
- Occupational therapy: Activities of daily living support
- Speech therapy: For associated communication difficulties
- Seizure control: Antiepileptic medications as needed
- Developmental support: Early intervention services for children
DCC is highly conserved across vertebrates:
- Humans: 1750 amino acids
- Mice: 1746 amino acids, 97% identity
- Zebrafish: 1728 amino acids
- Drosophila: DCC ortholog (fra), 1500 amino acids
The conservation of dependence receptor function suggests evolutionary importance.
DCC represents an ancient signaling system:
- Emerged with multicellular organisms
- Required for proper tissue patterning
- Adapted for nervous system development in vertebrates
- CRISPR: Gene editing for functional studies.
- Live imaging: Visualizing axon guidance in real-time.
- Proteomics: Mapping DCC interaction networks.
- In vitro: Neuronal cultures, organoids.
- In vivo: Mouse, zebrafish, C. elegans models.
- Computational: Network analysis, molecular dynamics.
- Fazeli et al., Phenotype of mice lacking netrin-1 receptors (1997) (1997)
- Bin et al., DCC in cortical development (2015) (2015)
- Manitt et al., DCC and neuropsychiatric disorders (2019) (2019)
- Horn et al., DCC mutations and mirror movements (2013) (2013)
- Shetty et al., DCC in synapse formation (2013) (2013)
- Petzold et al., DCC in neurological diseases (2009) (2009)
- Levelt et al., Netrin-1/DCC signaling in the brain (2012) (2012)
- Yetubay et al., DCC function in neuronal migration (2020) (2020)
- [Unknown, DCC research (n.d.)](https://doi.org/10.1016/s0166-2236(97)
- Unknown, DCC research (2019)
- Unknown, DCC research (n.d.)